Rainbow Childrens Medicare schedules investor meetings for Sep 18-22
- Rainbow Childrens Medicare schedules investor meetings for Sep 18-22, 2026
- Engagements include Kotak Healthcare Forum and J.P. Morgan Flagship Conference
- All meetings are in-person group sessions held in Mumbai
- No UPSI will be shared during these investor interactions

*this image is generated using AI for illustrative purposes only.
Rainbow Children's Medicare Limited Rainbow Children's Medicare has announced a schedule of in-person meetings with analysts and institutional investors for September 18 to 22, 2026.
The healthcare company will engage with stakeholders at three major financial forums in Mumbai during this period. These interactions are part of the firm's regular investor relations activities under SEBI Listing Regulations.
Meeting Schedule
The company confirmed that no Unpublished Price Sensitive Information (UPSI) will be shared during these engagements. The schedule is subject to change due to exigencies.
| Date | Event | Mode | Venue | Type |
|---|---|---|---|---|
| September 18, 2026 | Kotak Healthcare Forum 2026 | In-Person | Mumbai | Group |
| September 21, 2026 | Anand Rathi G-200 Summit 2026 | In-Person | Mumbai | Group |
| September 22, 2026 | J.P. Morgan Flagship India Conference | In-Person | Mumbai | Group |
Regulatory Disclosure
The intimation was issued pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shreya Mitra, Company Secretary and Compliance Officer, signed the disclosure on September 11, 2026.
The company's registered office is located in Hyderabad, Telangana.
Historical Stock Returns for Rainbow Childrens Medicare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.12% | -5.64% | -5.02% | +17.48% | -0.90% | +204.89% |
How might Rainbow Children's Medicare's presentations at these high-profile forums influence institutional investor sentiment and stock valuation in the near term?
What specific growth metrics or expansion strategies is the company likely to highlight to justify its current market capitalization during these meetings?
Could the timing of these investor interactions signal an upcoming strategic announcement, such as new hospital acquisitions or partnerships, despite the UPSI restriction?
































